Eliksa Therapeutics
Doylestown · Founded 2021
About Eliksa Therapeutics
Eliksa Therapeutics is a biotechnology company that develops regenerative medicine.
Company Facts
- Founded: 2021
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Oct 2025)
- Website: https://www.eliksa.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/eliksa-therapeutics-2231212 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.